The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). The association of those two diseases is known for decades, yet the contribution of IBD in the development and outcomes of PSC remain sunclear. Morever, the presence of IBD among patients with PSC affects the medical and surgical management of these patients. Patients with PSC should understand the relationship and impact of IBD on PSC.
In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients.
Join others discussing PSC
Liked by Rosemary, Volunteer Mentor